Max Healthcare Institute knowledgeable exchanges that its Board of Administrators is scheduled to satisfy on Could 21, 2026, to think about and approve the corporate’s standalone and consolidated monetary outcomes for the quarter and monetary yr ended March 31, 2026. The board may even think about recommending a last dividend for FY26.
The corporate disclosed the event by means of a regulatory submitting submitted to each the Nationwide Inventory Trade (NSE) and BSE on Thursday.
“We want to inform {that a} assembly of the Board of Administrators of the Firm is scheduled to be held on Thursday, Could 21, 2026, inter-alia, to:
think about and approve standalone and consolidated monetary outcomes of the Firm for the quarter and monetary yr ended March 31, 2026 (“Monetary Outcomes”); and advocate last dividend, if any, on fairness shares of the Firm for the monetary yr ended March 31, 2026,” it stated within the change submitting.
Max Healthcare additionally knowledgeable the exchanges that the buying and selling window for dealing within the firm’s securities will proceed to stay closed for designated individuals and their quick kinfolk until 48 hours after the declaration of monetary outcomes.
Max Healthcare inventory efficiency
Whereas the inventory has added 6% within the final 1 month, it has shed 4.5% up to now 6 months and 11% within the final 1 yr. Nonetheless, in 5 years, it has given multibagger returns, hovering 378%.
The healthcare inventory had hit its 52-week excessive of ₹1,314.30 in July 2025 and 52-week low of ₹903.50 in April 2026.
Simply in as we speak’s offers, the inventory added 1% to its day’s excessive of ₹1,060.
Max Healthcare Q3 Outcomes
Max Healthcare Institute reported a combined efficiency for the third quarter of FY26, as greater realisations and regular income development supported earnings, whereas margins and working metrics weakened on a sequential foundation.
The corporate posted income of ₹2,484 crore in Q3FY26, up 9% from ₹2,281 crore within the corresponding quarter final yr. EBITDA elevated 5% year-on-year to ₹633 crore in contrast with ₹603 crore in Q3FY25, though EBITDA margin moderated to 25.5% from 26.4% a yr in the past.
Revenue after tax stood at ₹344 crore, registering a 9% rise year-on-year, supported by improved realisations regardless of softer working tendencies throughout the quarter.
On a quarter-on-quarter foundation, nevertheless, efficiency softened. Income declined from ₹2,580 crore reported within the earlier quarter, whereas EBITDA dropped from ₹694 crore. Internet revenue additionally fell sharply from ₹554 crore in Q2FY26, reflecting seasonal softness and short-term disruptions that weighed on total operations.
Disclaimer: This story is for academic functions solely. Please seek the advice of with an funding advisor earlier than making any funding choices.
